Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 175.14
0.292 %
$ 79 B
Market Cap
32.86
P/E
BALANCE SHEET
14.3 B
ASSETS
9.3 B
LIABILITIES
5 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Zoetis Inc.
| Current Assets | 6.34 B |
| Cash & Short-Term Investments | 2.04 B |
| Receivables | 1.3 B |
| Other Current Assets | 3 B |
| Non-Current Assets | 7.94 B |
| Long-Term Investments | 23 M |
| PP&E | 3.43 B |
| Other Non-Current Assets | 4.49 B |
| Current Liabilities | 1.89 B |
| Accounts Payable | 411 M |
| Short-Term Debt | 3 M |
| Other Current Liabilities | 1.48 B |
| Non-Current Liabilities | 7.41 B |
| Long-Term Debt | 6.75 B |
| Other Non-Current Liabilities | 654 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Cash & Cash Equivalents | 2 041.0 | 3 577.0 | 3 482.0 | 3 602.0 | 1 932.0 | 1 602.0 | 1 564.0 | 727.0 | 1 154.0 | 882.0 | 610.0 | 317.0 | 79.0 | 63.0 | |
| Short Term Investments | 0 | 0 | 0 | 2.0 | 4.0 | 99.0 | 0 | 17.0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Receivables | 1 304.0 | 1 215.0 | 1 133.0 | 1 013.0 | 1 086.0 | 1 036.0 | 998.0 | 913.0 | 937.0 | 980.0 | 1 138.0 | 900.0 | 871.0 | 773.0 | |
| Inventory | 2 564.0 | 2 345.0 | 1 923.0 | 1 628.0 | 1 410.0 | 1 391.0 | 1 427.0 | 1 502.0 | 1 467.0 | 1 289.0 | 1 293.0 | 1 345.0 | 1 063.0 | 995.0 | |
| Other Current Assets | 434.0 | 365.0 | 389.0 | 366.0 | 318.0 | 271.0 | 228.0 | 248.0 | 272.0 | 314.0 | 316.0 | 302.0 | 298.0 | 285.0 | |
| Total Current Assets | 6 343.0 | 7 506.0 | 6 930.0 | 6 611.0 | 4 748.0 | 4 399.0 | 4 217.0 | 3 390.0 | 3 830.0 | 3 465.0 | 3 357.0 | 2 864.0 | 2 311.0 | 2 116.0 | |
| PP&E | 3 434.0 | 2 973.0 | 2 603.0 | 2 394.0 | 2 129.0 | 1 658.0 | 1 435.0 | 1 381.0 | 1 307.0 | 1 318.0 | 1 295.0 | 1 241.0 | 1 243.0 | 1 148.0 | |
| Intangible Assets | 1 338.0 | 1 380.0 | 1 474.0 | 1 710.0 | 1 890.0 | 2 046.0 | 1 269.0 | 1 228.0 | 1 190.0 | 727.0 | 803.0 | 868.0 | 928.0 | 924.0 | |
| Goodwill | 2 759.0 | 2 746.0 | 2 682.0 | 2 694.0 | 2 592.0 | 2 519.0 | 1 510.0 | 1 481.0 | 1 455.0 | 976.0 | 982.0 | 985.0 | 989.0 | 934.0 | |
| Long Term Investments | 23.0 | 31.0 | 33.0 | 22.0 | 25.0 | 10.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Long Term Assets | 183.0 | 116.0 | 78.0 | 84.0 | 73.0 | 84.0 | 75.0 | 73.0 | 49.0 | 67.0 | 58.0 | 88.0 | 97.0 | 92.0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 14 286.0 | 14 925.0 | 13 900.0 | 13 609.0 | 11 545.0 | 10 777.0 | 8 586.0 | 7 649.0 | 7 913.0 | 6 607.0 | 6 558.0 | 6 262.0 | 5 711.0 | 5 284.0 | |
| LIABILITIES | |||||||||||||||
| Accounts Payable | 411.0 | 405.0 | 436.0 | 457.0 | 301.0 | 313.0 | 261.0 | 265.0 | 293.0 | 290.0 | 506.0 | 319.0 | 214.0 | 206.0 | |
| Short Term Debt | 3.0 | 1 352.0 | 0 | 604.0 | 500.0 | 9.0 | 0 | 0 | 405.0 | 7.0 | 15.0 | 73.0 | 0 | 38.0 | |
| Other Current Liabilities | 1 365.0 | 1 253.0 | 1 323.0 | 1 063.0 | 969.0 | 866.0 | 773.0 | 781.0 | 1 020.0 | 763.0 | 854.0 | 701.0 | 611.0 | 540.0 | |
| Total Current Liabilities | 1 889.0 | 3 167.0 | 1 797.0 | 2 170.0 | 1 806.0 | 1 223.0 | 1 094.0 | 1 117.0 | 1 781.0 | 1 086.0 | 1 415.0 | 1 123.0 | 843.0 | 808.0 | |
| Long Term Debt | 6 752.0 | 6 738.0 | 6 743.0 | 6 758.0 | 6 111.0 | 6 443.0 | 4 953.0 | 4 468.0 | 4 463.0 | 3 643.0 | 3 642.0 | 509.0 | 453.0 | 573.0 | |
| Deferred Tax Income | 146.0 | 142.0 | 320.0 | 378.0 | 434.0 | 474.0 | 380.0 | 244.0 | 264.0 | 277.0 | 322.0 | 323.0 | 311.0 | 218.0 | |
| Other Liabilities | 508.0 | 475.0 | 496.0 | 530.0 | 486.0 | 452.0 | 373.0 | 321.0 | 314.0 | 264.0 | 217.0 | 266.0 | 124.0 | 141.0 | |
| Total Liabilities | 9 295.0 | 10 522.0 | 9 356.0 | 9 836.0 | 8 837.0 | 8 592.0 | 6 800.0 | 6 150.0 | 6 822.0 | 5 270.0 | 5 596.0 | 2 221.0 | 1 975.0 | 1 940.0 | |
| EQUITY | |||||||||||||||
| Common Stock | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 4 183.0 | 0 | 0 | |
| Retained Earnings | 10 295.0 | 8 668.0 | 7 186.0 | 5 659.0 | 4 427.0 | 3 270.0 | 2 109.0 | 1 477.0 | 876.0 | 709.0 | 276.0 | 0 | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | (839.0) | (817.0) | (764.0) | (730.0) | (726.0) | (629.0) | (505.0) | (598.0) | (622.0) | (361.0) | (219.0) | (157.0) | (65.0) | (74.0) | |
| Total Equity | 4 991.0 | 4 403.0 | 4 544.0 | 3 773.0 | 2 708.0 | 2 185.0 | 1 786.0 | 1 499.0 | 1 091.0 | 1 337.0 | 962.0 | 4 041.0 | 3 736.0 | 3 344.0 | |
| Total Liabilities and Equity | 14 286.0 | 14 925.0 | 13 900.0 | 13 609.0 | 11 545.0 | 10 777.0 | 8 586.0 | 7 649.0 | 7 913.0 | 6 607.0 | 6 558.0 | 6 262.0 | 5 711.0 | 5 284.0 | |
| SHARES OUTSTANDING | |||||||||||||||
| Common Shares Outstanding | 461.2 | 468.9 | 474.3 | 475.5 | 478.1 | 483.1 | 489.9 | 495.7 | 499.7 | 501.1 | 500.0 | 500.0 | 478.1 | 478.1 | 478.1 |